Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-61348847 |
| Mobile: | 14775486675 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Cefixime Impurity 1 | C8H9N3O5S | 80544-17-8 | Details |
| Cinchocaine EP Impurity C ;Dibucaine Impurity C) | C16H21N3O2 | 87864-08-2 | Details |
| Clindamycin 2,4-Diphosphate | C18H35ClN2O11P2S | 1309048-48-3 | Details |
| Cinchocaine EP Impurity D;2-Butoxy-4-quinolinecarboxylic Acid; 2-Butoxy-cinchoninic Acid | C14H15NO3 | 10222-61-4 | Details |
| Clopidogrel Related Compound A ;(S)-Clopidogrel Carboxylic Acid | C15H14ClNO2S | 144457-28-3 | Details |
| Citalopram Dimethylaminobutanone Di-Oxalate ;5-Dimethylaminobutyryl Citalopram Di-Oxalate | Details |
| Domperidone EP Impurity B | C13H14ClN3O2 | 1346598-11-5 | Details |
| Domperidone EP Impurity A | C12H14ClN3O | 53786-28-0 | Details |
| Dibenzo[b,f][1,4]thiazepin-11(10H)-one, 5-oxide | C13H9NO2S | 20290-48-6 | Details |
| Dasatinib Dimeric Impurity;2,2'-[1,4-Piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide | C36H34Cl2N12O2S2 | 910297-61-9 | Details |
| Domperidone EP Impurity E | C32H34ClN7O3 | 1346602-50-3 | Details |
| Dabigatran etexilate Impurity F | C19H20N4O3 | 1702936-92-2 | Details |
| Domperidone EP Impurity F | C37H42Cl2N8O3 | 1391053-55-6 | Details |
| Glycyrrhizic Acid (Glycyrrhizin) | C42H62O16 | 1405-86-3 | Details |
| Glycopyrronium impurity M | C12H14O | 5422-88-8 | Details |
| Donepezil Deoxy Impurity | C24H31NO2 | 844694-84-4 | Details |
| Donepezil Benzyl Bromide Impurity | C31H36BrNO3 | 844694-85-5 | Details |
| Doxofylline Impurity 2 | C9H10N4O3 | 5614-53-9 | Details |
| Donepezil Dehydrodeoxy Impurity | C24H29NO2 | 120013-45-8 | Details |
| Domperidone Impurity C | C22H24ClN5O3 | 118435-03-3 | Details |
| Irbesartan Impurity 7 | C25H29N3O2 | 141745-71-3 | Details |
| Doxofylline Impurity 1 | C10H16N4O3 | 1429636-74-7 | Details |
| Ibuprofen EP Impurity K | C10H10O3 | 43153-07-7 | Details |
| ethyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate | C12H12F2O2 | 1006376-61-9 | Details |
| Fludarabine Phosphate EP Impurity B | C5H5N5O | 149297-79-0 | Details |
| Glycopyrronium impurity K | C13H16O2 | 3900-93-4 | Details |
| Fludarabine Phosphate EP Impurity F | C12H18N5O8P | 159002-28-5 | Details |
| Glycopyrronium impurity H | C9H8O3 | 15206-55-0 | Details |
| Quetiapine EP Impurity P;Quetiapine N-Ethyl Impurity;11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine hydrochloride | C19H21N3S | 1011758-03-4 | Details |
| Rapamycin ;Sirolimus | C51H79NO13 | 53123-88-9 | Details |
| ortho-Hydroxy Atorvastatin Calcium Salt | C33H37CaFN2O6 | 265989-46-6 | Details |
| Rivaroxaban Diamine Impurity | C25H24Cl2N4O6S2 | 1807455-76-0 | Details |
| Lansoprazole EP Impurity B ;Lansoprazole Sulfone | C16H14F3N3O3S | 131926-99-3 | Details |
| Rivaroxaban Triamine Impurity | C38H36Cl2N6O10S2 | 1632463-24-1 | Details |
| Linezolid Diphthalimide;2,2'-(3,3'-(3-Fluoro-4-morpholinophenylazanediyl)bis(2-hydroxypropane-3,1-diyl))diidoindoline-1,3-dione | C32H31FN4O7 | 1798014-14-8 | Details |
| Olmesartan Acid | C24H26N6O3 | 144689-24-7 | Details |
| Meloxicam Related Compound A | C12H13NO5S | 24683-26-9 | Details |
| Olmesartan Medoxomil EP Impurity C | C29H28N6O5 | 879562-26-2 | Details |
| Lansoprazole EP Impurity C | C16H14F3N3OS | 103577-40-8 | Details |
| para-Hydroxy Atorvastatin Calcium Salt | C66H70CaF2N4O12 | 265989-44-4 | Details |
| N-[(1-Methyl-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester formate | C20H22N4O5 | Details |
| Omeprazole Impurity H215/01 | C16H17N3O3S | 301669-82-9 | Details |
| Meloxicam Related Compound B | C4H6N2S | 7305-71-7 | Details |
| Rabeprazole EP Impurity D | C18H21N3O4S | 924663-38-7 | Details |
| Omeprazole Related Compound 6 | C9H13NO2 | 86604-80-0 | Details |
| Rabeprazole Impurity C | C14H12ClN3OS | 168167-42-8 | Details |
| Rabeprazole Related Compound A | C14H11N3O3 | 1163685-30-0 | Details |
| Lansoprazole EP Impurity A ;Lansoprazole N-Oxide | C16H14F3N3O3S | 213476-12-1 | Details |
| N-Butyryl-4-(5-methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide | C20H21N2NaO4S | 198470-92-7 | Details |
| Rabeprazole Sulfide | C18H21N3O2S | 117977-21-6 | Details |
| Quetiapine EP Impurity H;2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol N-oxide | C21H25N3O3S | 1076199-40-0 | Details |
| Rivaroxaban Impurity 1 | C18H20ClN3O4S | 721401-53-2 | Details |
| Meloxicam Impurity E | C11H11NO5S | 35511-15-0 | Details |
| N-[3-chloro-2-(R)-hydroxypropyl]-3-fluoro-4-(morpholin-4-yl)aniline | C13H18ClFN2O2 | 868405-66-7 | Details |
| Rabeprazole EP Impurity E | C15H15N3O2S | 102804-77-3 | Details |
| Rivaroxaban ImpVI | C22H19N3O6 | 446292-08-6 | Details |
| Omeprazole EP Impurity B | C16H17N3O2S | 110374-16-8 | Details |
| Tacrolimus | C44H69NO12 | 104987-11-3 | Details |
| (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide | C10H7F2N3O | 378236-67-0 | Details |
| Succinic acid mono-(1-dimethylaminomethyl-2-{2-[2-(3-methoxy-phenyl)-vinyl]-phenoxy}-ethyl) ester | C24H29NO6 | 1659311-42-8 | Details |
| Rivaroxaban ImpIII | C19H19N3O5S | 1415566-28-7 | Details |
| (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol hydrochloride | C13H20FN3O2 | 333753-72-3 | Details |
| Baccatin III | C31H38O11 | 27548-93-2 | Details |
| 2-[(2S)-3-Chloro-2-hydroxypropyl]-1H-isoindole-1,3(2H)-dione | C11H10ClNO3 | 148857-42-5 | Details |
| 3-methyl-4,5-diphenylisoxazole | C16H13NO | 75115-00-3 | Details |
| 1,1,2-Triethoxy-ethane | C8H18O3 | 4819-77-6 | Details |
| 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | C23H28FN3O4 | 152542-03-5 | Details |
| (S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoic acid | C14H13N3O3 | 114457-94-2 | Details |
| (S)-N-(3-chloro-2-hydroxy-1-propyl)acetamide | C5H10ClNO2 | 224323-47-1 | Details |
| Acetic propionic anhydride;acetyl propanoate | C5H8O3 | 13080-96-1 | Details |
| 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione | C23H25FN4O3 | 1189516-65-1 | Details |
| Rebeprazole sulfone N-oxide | C18H21N3O5S | 924663-37-6 | Details |
| 9-[(2S)-2-(diethoxyphosphorylmethoxy)propyl]purin-6-amine | C13H22N5O4P | 180587-75-1 | Details |
| Bortezomib USP Related Compoud B;N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide | C14H14N4O2 | 289472-80-6 | Details |
| (R)-3-methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butylboronic acid | C28H34BN5O5 | 1194235-41-0 | Details |
| (3R,4R,5R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol | C21H25ClO6 | 1469910-83-5 | Details |
| 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol; Quetiapine EP Impurity I; | C19H21N3OS | 329216-67-3 | Details |
| Rivaroxaban ImpIV | C19H17Cl2N3O5S | 1770812-37-7 | Details |
| 4-methylbenzenesulfonamide; p-Toluenesulfonamide; | C7H9NO2S | 70-55-3 | Details |
| brevifolin carboxylic acid;brevifolincarboxylic acid | C13H8O8 | 18490-95-4 | Details |
| 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine; Quetiapine EP Impurity D;Quetiapine Dimer Impurity | C30H24N4S2 | 945668-94-0 | Details |
| 2-{2-[2-(3-Methoxy-phenyl)-ethyl]-phenoxymethyl}-oxirane | C18H20O3 | 1140968-46-2 | Details |
| Betahistine EP Impurity C TriHCl | C8H12N2 | Details |
| (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-Acetate; (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol Acetate (Ester) | Details |
| Product Total： Product Page： | ||||
| 1 | ||||